Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer

miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells

(2012) Hai-jiao Yan et al.   DIGESTIVE DISEASES AND SCIENCES

Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma

(2012) Dong Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Efficacy of IGF-I Receptor Monoclonal Antibody against Human Gastrointestinal Carcinomas is Independent of k-ras Mutation Status

(2011) M. Ii et al.   CLINICAL CANCER RESEARCH

Novel Medical Therapies of Recurrent and Metastatic Gastroenteropancreatic Neuroendocrine Tumors

(2011) M. D. Miljković et al.   DIGESTIVE DISEASES AND SCIENCES

Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro

(2011) Shanrong Shu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Biological Rationale and Current Clinical Experience With Anti-Insulin-Like Growth Factor 1 Receptor Monoclonal Antibodies in Treating Sarcoma

(2010) David Olmos et al.   CANCER JOURNAL

Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters

(2009) Qi-Lian Liang et al.   MEDICAL ONCOLOGY

AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells

(2009) P. J. Beltran et al.   MOLECULAR CANCER THERAPEUTICS

Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells

(2008) Hua Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT